Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Song Wan
Jean-Louis Vincent
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wan, S.
Right arrow Articles by Vincent, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wan, S.
Right arrow Articles by Vincent, J.-L.
Asian Cardiovasc Thorac Ann 1998;6:78-79
© 1998 Asia Publishing EXchange Pte Ltd


LETTER TO THE EDITOR

Can Cardiopulmonary Bypass Be Less Aggressive?

Wan Song, MD, PhD, Jean-Marie DeSmet, MD, Jean-Louis Vincent, MD, PhD1

Division of Cardiothoracic Surgery Prince of Wales Hospital The Chinese University of Hong Kong Shatin, Hong Kong People's Republic of China
Department of Cardiac Surgery
1 Department of Intensive Care University Hospital Erasme Free University of Brussels Route de Lennik 808 Brussels B-1070, Belgium
Less invasive cardiac surgery has recently become a focus of intense discussion especially with renewed interest in so-called off-pump operations. Avoiding the use of cardiopulmonary bypass (CPB) during open-heart surgery, in particular for coronary artery bypass grafting, sounds less invasive since it has been clearly demonstrated that CPB is associated with a systemic inflammatory response that may contribute to the postoperative morbidity.1,2 In a recent survey, 81% of 137 practising cardiothoracic surgeons shared the opinion that avoiding CPB is less invasive, although 56% of them did not believe that a short period of CPB was really detrimental.3 However, scientific evidence especially long-term follow-up data has yet to prove the real benefits of off-pump practice. Thus, before trying to avoid the routine use of CPB, it is probably more important to ask the question if CPB could be less aggressive.

CPB carries less untoward effects today when compared with its infancy stage half a century ago, due to continued efforts to improve the managing protocol through a better understanding of the pathophysiologic concepts involved.2 From somehow physiological cross-circulation4 to the use of bubble and membrane oxygenators, CPB has been established as a safe procedure and has gained worldwide acceptance among cardiac surgeons. Recently developed therapies aimed at interfering with the inflammatory response have included the administration of pharmacological agents such as corticosteroids, aprotinin, and antioxidants, as well as modification of techniques and equipment by the use of heparin-coated CPB circuits, intraoperative leukocyte depletion, and ultrafiltration.2 These improved management modalities with complete revascularization have resulted in shorter recovery times5,6 as well as improved event-free long-term survival in patients undergoing coronary artery bypass grafting.7 In fact, it has been observed recently that there is no difference in the incidence of cerebral injury in patients undergoing coronary artery bypass grafting with and without CPB.8

The inflammatory reactions occurring during and after CPB are extremely complex. With a much improved knowledge of the pathophysiologic changes during CPB it is still possible to make CPB even less aggressive. For instance, the release of proinflammatory cytokines has been suggested to play a key role in the development of postoperative complications.9 However, an endogenous anti-inflammatory, potentially protective response is also associated with CPB, as reflected in the production of an anti-inflammatory cytokine interleukin-10 (IL-10) as well as a preconditioning effect involving the stimulation of myocardial alpha adrenergic receptors and adenosine receptors.9,10 It has been found that IL-10 may reduce pulmonary ischemia-reperfusion injury.11 Interestingly, neither the heart nor the lung12 but the liver13 is the major source of IL-10 during CPB, and the release of IL-10 is markedly increased in steroid-pretreated patients.9 To enhance IL-10 release in patients undergoing a longer duration of both CPB and cardiopulmonary ischemia, the timing of steroid administration can be crucial.14 Nevertheless, the balance between these proinflammatory and anti-inflammatory responses may be even more important. For example, in combination with the reduction of some other proinflammatory mediators, reduced IL-10 production has also been associated with the use of heparin-coated CPB circuits and, interestingly, this may lead to reduced myocardial injury in patients undergoing heart and heart-lung transplantation. (Authors' unpublished data).

Back to our question if CPB could be less aggressive. The answer is obvious. Therefore, the definition of less invasive cardiac surgery in the future may not be just off-pump but on-a-better-pump with not only enhanced biocompatibility of materials but also improved perioperative management.

REFERENCES

  1. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845–57.[Abstract]

  2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112:676–92.[Abstract/Free Full Text]

  3. Shennib H, Mack MJ, Lee AGL. A survey on minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1997;64:110–5.[Abstract/Free Full Text]

  4. Lillehei CW, Varco RL, Cohen M, et al. The first openheart repairs of ventricular septal defect, atrioventricular communis, and tetralogy of Fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up. Ann Thorac Surg 1986;41:4–21.[Abstract]

  5. Westaby S, Pillai R, Parry A, et al. Does modern cardiac surgery require conventional intensive care? Eur J Cardiothorac Surg 1993;7:313–8.[Abstract]

  6. Engelman RM, Rousou JA, Flack JE III, et al. Fast-track recovery of the coronary bypass patient. Ann Thorac Surg 1994;58:1742–6.[Abstract]

  7. Jones EL, Weintraub WS. The importance of completeness of revascularization during long-term follow-up after coronary artery operations. J Thorac Cardiovasc Surg 1996;112:227–37.[Abstract/Free Full Text]

  8. Browne S, Westaby S, Taggart DP. Neuropsychological and respiratory injury following CABG surgery with and without cardiopulmonary bypass [Abstract]. Proceedings of the 11th annual meeting of the European Association for Cardiothoracic Surgery; 1997 Sept 28–Oct 1; Copenhagen; p. l22.

  9. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63:269–76.[Abstract/Free Full Text]

  10. Burns PG, Krukenkamp IB, Caldarone CA, et al. Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 1995;92(Suppl II):II-447–51.

  11. Eppinger MJ, Ward PA, Bolling SF, Deeb GM. Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1996;112:1301–6.[Abstract/Free Full Text]

  12. Wan S, DeSmet JM, Barvais L, et al. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112:806–11.[Abstract/Free Full Text]

  13. Wan S, LeClerc JL, Schmartz D, et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997;133:335–9.[Medline]

  14. Wan S, DeSmet JM, Antoine M, et al. Steroid administration in heart and heart-lung transplantation: is the timing adequate? Ann Thorac Surg 1996;61:674–8.[Abstract/Free Full Text]





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Song Wan
Jean-Louis Vincent
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wan, S.
Right arrow Articles by Vincent, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wan, S.
Right arrow Articles by Vincent, J.-L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS